Xponance, Inc. Novo Cure LTD Transaction History

Xponance, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$12.42 - $17.29 $4,371 - $6,086	-352 Reduced 2.52%	13,623 $212,000
Q4 2023 Jan 31, 2024	SELL	$11.13 - $15.78 $4,452 - $6,312	-400 Reduced 2.78%	13,975 $208,000
Q3 2023 Oct 23, 2023	BUY	$16.15 - $42.35 $129 - $338	8 Added 0.06%	14,375 $232,000
Q2 2023 Jul 13, 2023	BUY	$40.29 - $82.51 $10,475 - $21,452	260 Added 1.84%	14,367 $596,000
Q1 2023 Apr 17, 2023	BUY	$56.44 - $118.81 $5,926 - $12,475	105 Added 0.75%	14,107 $848,000
Q4 2022 Jan 23, 2023	BUY	$63.98 - $85.37 $113,756 - $151,787	1,778 Added 14.55%	14,002 $0
Q3 2022 Oct 24, 2022	BUY	$67.99 - $89.57 $13,733 - $18,093	202 Added 1.68%	12,224 $929,000
Q2 2022 Aug 02, 2022	BUY	$56.6 - $89.9 $21,677 - $34,431	383 Added 3.29%	12,022 $836,000
Q1 2022 Apr 20, 2022	BUY	$60.15 - $84.52 $7,999 - $11,241	133 Added 1.16%	11,639 $964,000
Q4 2021 Jan 31, 2022	SELL	$75.08 - $121.99 $13,814 - $22,446	-184 Reduced 1.57%	11,506 $864,000
Q3 2021 Nov 05, 2021	SELL	$116.17 - $194.55 $31,830 - $53,306	-274 Reduced 2.29%	11,690 $1.36 Million
Q2 2021 Aug 12, 2021	BUY	$130.4 - $225.58 $204,728 - $354,160	1,570 Added 15.1%	11,964 $2.65 Million
Q1 2021 May 10, 2021	SELL	$124.11 - $190.17 $11,666 - $17,875	-94 Reduced 0.9%	10,394 $1.37 Million
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $9,645 - $14,976	86 Added 0.83%	10,488 $1.82 Million
Q3 2020 Oct 26, 2020	SELL	$58.05 - $111.31 $2,147 - $4,118	-37 Reduced 0.35%	10,402 $1.16 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $597,110 - $776,765	10,439 New	10,439 $619,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.88B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.